Caldera Therapeutics

Business Services · Massachusetts, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

300 Technology Sq Ste 8, Cambridge, Mass...

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About Caldera Therapeutics

Caldera Therapeutics is a clinical stage company developing CLD-423, a first-in-class bispecific antibody targeting the clinically validated IL-23p19 and TL1A pathways for the treatment of inflammatory bowel disease (IBD) and other immunologic and inflammatory diseases. Supported by leading biotech investors Atlas Venture, LAV, venBio, Omega Funds, Wellington Management and Janus Henderson Investors, Caldera has assembled a senior leadership team with deep experience in the discovery and development of IBD therapeutics and a proven track record of building biotechnology companies through to successful exits.Explore more
Caldera Therapeutics's Social MediaPopular SearchesCaldera TherapeuticsSIC Code 87,873NAICS Code 54,541Show more

Caldera Therapeutics Org Chart

Praveen Tipirneni, Chief Executive Officer at Caldera Therapeutics
United States flag for contact location.

Chief Executive Officer

PhoneEmail
Aaron Pelta, Chief Business Officer at Caldera Therapeutics
United States flag for contact location.

Chief Business Officer

PhoneEmail
Liangsu Wang, Chief Scientific Officer at Caldera Therapeutics
United States flag for contact location.

Chief Scientific Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
YH
United States flag for contact location.

Head Senior Director, CMC Operations

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Caldera Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Caldera Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Caldera Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Caldera Therapeutics.

Caldera Therapeutics financials insights

Gather financial insights about Caldera Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2026

Other Financing Round

$37.5M

Series A

$75M

See All Caldera Therapeutics's Financials Insights

Top Business Services Companies

Frequently Asked Questions Regarding Caldera Therapeutics

What is Caldera Therapeutics's official website?
Caldera Therapeutics's official website is www.calderatx.com
What is Caldera Therapeutics's Revenue?
Caldera Therapeutics's revenue is <$5 Million
What is Caldera Therapeutics's SIC code?
Caldera Therapeutics's SIC: 87,873
What is Caldera Therapeutics's NAICS code?
Caldera Therapeutics's NAICS: 54,541
How many employees does Caldera Therapeutics have?
Caldera Therapeutics has 1-10 employees
What industry does Caldera Therapeutics belong to?
Caldera Therapeutics is in the industry of: Business Services, Research & Development
What companies has Caldera Therapeutics acquired?
Caldera Therapeutics has acquired the companies: Synlogic
What does Caldera Therapeutics do?

Caldera Therapeutics is a clinical stage company developing CLD-423, a first-in-class bispecific antibody targeting the clinically validated IL-23p19 and TL1A pathways for the treatment of inflammatory bowel disease (IBD) and other immunologic and inflammatory diseases. Supported by leading biotech investors Atlas Venture, LAV, venBio, Omega Funds,... Wellington Management and Janus Henderson Investors, Caldera has assembled a senior leadership team with deep experience in the discovery and development of IBD therapeutics and a proven track record of building biotechnology companies through to successful exits.Read More

What are Caldera Therapeutics social media links?
Caldera Therapeutics Linkedin page
Who invested in Caldera Therapeutics?
Caldera Therapeutics has 5 investors including Omega Alpha Spac, Janus Henderson Investors, Atlas Venture and venBio Partners.
Is Caldera Therapeutics a public company?
Caldera Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Caldera Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.